Free tool
FAERS Monitor: Children'S Allegra Hives
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021909 or its brand name (Children'S Allegra Hives, Fexofenadine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
6,454
Serious
4,307
67% of reports
Hospitalization
2,016
Death reported
426
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective485
- nausea352
- diarrhoea350
- headache348
- pruritus328
- fatigue323
- dizziness290
- dyspnoea283
- rash283
- off label use224
- pyrexia222
- pain221
- pneumonia209
- malaise207
- cough198
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 148 |
| 2005 | 140 |
| 2006 | 29 |
| 2007 | 31 |
| 2008 | 37 |
| 2009 | 48 |
| 2010 | 20 |
| 2011 | 36 |
| 2012 | 113 |
| 2013 | 146 |
| 2014 | 148 |
| 2015 | 145 |
| 2016 | 200 |
| 2017 | 250 |
| 2018 | 319 |
| 2019 | 404 |
| 2020 | 493 |
| 2021 | 515 |
| 2022 | 464 |
| 2023 | 586 |
| 2024 | 650 |
| 2025 | 823 |
| 2026 | 709 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pruritusSignal | 328 | 2.8 | 2.5 | 380 |
| coughSignal | 198 | 2.3 | 2.0 | 146 |
| rashSignal | 283 | 2.1 | 1.9 | 169 |
| pneumoniaSignal | 209 | 2.1 | 1.8 | 122 |
| pyrexiaSignal | 222 | 2.1 | 1.8 | 127 |
| dizziness | 290 | 1.9 | 1.7 | 125 |
| headache | 348 | 1.8 | 1.6 | 129 |
| diarrhoea | 350 | 1.8 | 1.6 | 119 |
| dyspnoea | 283 | 1.6 | 1.5 | 70 |
| malaise | 207 | 1.5 | 1.3 | 39 |
| nausea | 352 | 1.4 | 1.3 | 51 |
| fatigue | 323 | 1.4 | 1.2 | 30 |
| drug ineffective | 485 | 1.2 | 1.1 | 17 |
| pain | 221 | 1.2 | 1.0 | 6 |
| off label use | 224 | 0.8 | 0.7 | 8 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.